News

Featured News

Flexibility, creativity, and dedication to make better therapeutics are at the heart of what we do. Read more on recent updates and highlights around our contract drug manufacturing activities.

BIOVECTRA is Honoured With 2025 CDMO Leadership Award, BIOLOGICS — Industry Recognizes BIOVECTRA’s Excellence in Microbial Fermentation, Recombinant Protein Production, and Aseptic Fill-Finish Capabilities.

March 6, 2025

CHARLOTTETOWN, Prince Edward Island – BIOVECTRA, a part of Agilent Technologies Inc., is a leading North American CDMO specializing in biologics, mRNA therapeutics, and complex chemistry, proudly announces it is the recipient of the 2025 Outsourced Pharma CDMO Leadership Award in the category of biologics. The award recognizes BIOVECTRA’s performance in key areas such as quality, reliability, and technical capability.[…]

Press Release

BIOVECTRA Inc. to Open New Microbial Fermentation and Complex Chemistry Site in December 2017

$30 million investment increases BioVectra’s total manufacturing capacity by 40% […]

24 May 2017

Uncategorized

Join us in New York City for DCAT Week 2017 – March 20-23

March 6, 2017 Join us in New York City for DCAT Week 2017 – March 20-23 Join us in New York City for DCAT Week […]

6 March 2017

Nine people in formal attire stand together indoors, smiling. An American flag is visible in the background on the left side.

News Brief

DCAT Announces New Advisory Council Member

November 1, 2016 PRESS RELEASE DCAT Announces New Advisory Council Member Robbinsville, NJ, November 1, 2016 – The Drug, Chemical & Associated Technology Association (DCAT) […]

5 March 2017

A person in protective gear examines industrial equipment in a complex facility filled with pipes and machinery.

Article

BIOVECTRA Goes Global

Some 45 years ago, Regis Duffy saw large-scale opportunity in the pharmaceutical and diagnostic marketplace and created the origins of BIOVECTRA Inc. in a Charlottetown […]

26 February 2017